132 related articles for article (PubMed ID: 23971175)
1. Assessment of lung tumor response by perfusion CT.
Coche E
JBR-BTR; 2013; 96(3):172-4. PubMed ID: 23971175
[TBL] [Abstract][Full Text] [Related]
2. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience.
Fraioli F; Anzidei M; Zaccagna F; Mennini ML; Serra G; Gori B; Longo F; Catalano C; Passariello R
Radiology; 2011 May; 259(2):574-82. PubMed ID: 21357523
[TBL] [Abstract][Full Text] [Related]
3. Value of whole-tumor dual-input perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer.
Li XS; Fan HX; Fang H; Huang H; Song YL; Zhou CW
AJR Am J Roentgenol; 2014 Nov; 203(5):W497-505. PubMed ID: 25341164
[TBL] [Abstract][Full Text] [Related]
4. First-pass CT perfusion in small peripheral lung cancers: effect of the temporal interval between scan acquisitions on the radiation dose and quantitative vascular parameters.
Shan F; Xing W; Qiu J; Zhang Z; Yang S
Acad Radiol; 2013 Aug; 20(8):972-9. PubMed ID: 23830603
[TBL] [Abstract][Full Text] [Related]
5. CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates.
Chu LL; Knebel RJ; Shay AD; Santos J; Badawi RD; Gandara DR; Knollmann FD
Eur Radiol; 2018 Dec; 28(12):5069-5075. PubMed ID: 29869174
[TBL] [Abstract][Full Text] [Related]
6. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy.
Wang J; Wu N; Cham MD; Song Y
AJR Am J Roentgenol; 2009 Oct; 193(4):1090-6. PubMed ID: 19770333
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion.
Bevilacqua A; Barone D; Malavasi S; Gavelli G
Acad Radiol; 2014 Nov; 21(11):1416-26. PubMed ID: 25300721
[TBL] [Abstract][Full Text] [Related]
8. Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.
Tacelli N; Santangelo T; Scherpereel A; Duhamel A; Deken V; Klotz E; Cortot A; Lafitte JJ; Wallyn F; Remy J; Remy-Jardin M
Eur Radiol; 2013 Aug; 23(8):2127-36. PubMed ID: 23553586
[TBL] [Abstract][Full Text] [Related]
9. Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors.
Gibaldi A; Barone D; Gavelli G; Malavasi S; Bevilacqua A
Acad Radiol; 2015 Jan; 22(1):58-69. PubMed ID: 25481516
[TBL] [Abstract][Full Text] [Related]
10. Effect of duration of scan acquisition on CT perfusion parameter values in primary and metastatic tumors in the lung.
Ng CS; Chandler AG; Wei W; Anderson EF; Herron DH; Kurzrock R; Charnsangavej C
Eur J Radiol; 2013 Oct; 82(10):1811-8. PubMed ID: 23769187
[TBL] [Abstract][Full Text] [Related]
11. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.
Kambadakone A; Yoon SS; Kim TM; Karl DL; Duda DG; DeLaney TF; Sahani DV
AJR Am J Roentgenol; 2015 Jan; 204(1):W11-8. PubMed ID: 25539263
[TBL] [Abstract][Full Text] [Related]
12. Liver perfusion CT during hepatic arteriography for the hepatocellular carcinoma: dose reduction and quantitative evaluation for normal- and ultralow-dose protocol.
Watanabe S; Katada Y; Gohkyu M; Nakajima M; Kawabata H; Nozaki M
Eur J Radiol; 2012 Dec; 81(12):3993-7. PubMed ID: 22980216
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology?
Goh V; Ng QS; Miles K
Invest Radiol; 2012 Jan; 47(1):2-4. PubMed ID: 21808202
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of computed tomography perfusion parameters in non-small-cell-lung-cancer and its relationship to histology, size, stage an treatment response.
Trinidad López C; Souto Bayarri M; Oca Pernas R; Delgado Sánchez-Gracián C; González Vázquez M; Vaamonde Liste A; Tardáguila De La Fuente G; De La Fuente Aguado J
Clin Imaging; 2018; 50():5-12. PubMed ID: 29223410
[TBL] [Abstract][Full Text] [Related]
15. Assessment of 64-slice spiral computed tomography with perfusion weighted imaging in the early diagnosis of ground-glass opacity lung cancer.
Lv Y; Jin Y; Xu D; Yan Q; Liu G; Zhang H; Yuan D; Bao J
J BUON; 2016; 21(4):954-957. PubMed ID: 27685919
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of MDCT and quantitative first-pass perfusion in lung cancers.
Yildirim IO; Baysal T; Celik MR
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2390-5. PubMed ID: 24065234
[TBL] [Abstract][Full Text] [Related]
17. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
18. CTA combined with CT perfusion for assessing the efficacy of anti-angiogenic therapy in rabbit VX2 tumors.
Wang H; Zheng LF; Feng Y; Xie XQ; Yang XM; Zhang GX
Acad Radiol; 2012 Mar; 19(3):358-65. PubMed ID: 22310524
[TBL] [Abstract][Full Text] [Related]
19. Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinoma.
Preda L; Calloni SF; Moscatelli ME; Cossu Rocca M; Bellomi M
Biomed Res Int; 2014; 2014():917150. PubMed ID: 25140324
[TBL] [Abstract][Full Text] [Related]
20. Liver perfusion with dynamic multidetector-row computed tomography as an objective method to evaluate the efficacy of chemotherapy in patients with colorectal cancer.
Pauls S; Gabelmann A; Heinz W; Fröhlich E; Juchems MS; Brambs HJ; Schmidt SA
Clin Imaging; 2009; 33(4):289-94. PubMed ID: 19559351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
